- CAREER COLUMN
The good side of science: why I tweeted 31 reasons to love your career
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-023-01027-8
This is an article from the Nature Careers Community, a place for Nature readers to share their professional experiences and advice. Guest posts are encouraged.
Competing Interests
J.R. is an employee of Vanderbilt University Medical Center and a founder, scientific advisory board member and stockholder of Sitryx Therapeutics, a scientific advisory board member and stockholder of Caribou Biosciences and a scientific advisory board member of Nirogy Therapeutics. J.R. has consulted for Merck and Pfizer, has received speaker honorarium from Abbvie and has received research support from Incyte in the past three years.